Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the "cOPA" pilot randomized trial

Mucosal Immunology

Volumn 4, Issue 5, 2011, Pages 554-563

  Gori, A ^a   Rizzardini, G ^b   Van'T Land, B ^c,d   Amor, K B ^c   Van Schaik, J ^c   Torti, C ^e   Quirino, T ^f   Tincati, C ^g   Bandera, A ^a   Knol, J ^c   Benlhassan Chahour, K ^h   Trabattoni, D ^g   Bray, D ^h   Vriesema, A ^c   Welling, G ⁱ   Garssen, J ^c,d   Clerici, M ^g  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c DANONE RESEARCH   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF BRESCIA   (Italy)

^f BUSTO ARSIZIO HOSPITAL   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h ImmunoClin   (France)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; OLIGOSACCHARIDE; PECTIN; PREBIOTIC AGENT; PROTEIN HYDROLYSATE;

ABDOMINAL DISTENSION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIFIDOBACTERIUM; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM HISTOLYTICUM; CLOSTRIDIUM LITUSEBURENSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; DRUG WITHDRAWAL; EUBACTERIUM; EUBACTERIUM RECTALE; FEMALE; FLATULENCE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOSTIMULATION; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PRODUCT SAFETY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; T LYMPHOCYTE ACTIVATION;

EID: 84860390171     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2011.15     Document Type: Article

References (51)

1. Brenchley, J. M. et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749-759 (2004). (Pubitemid 39299461)
2. Mehandru, S. et al. The gastrointestinal tract is critical to the patho genesis of acute HIV-1 infection. J. Allergy Clin. Immunol. 116, 419-422 (2005). (Pubitemid 41096552)
3. Guadalupe, M. et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708-11717 (2003). (Pubitemid 37271669)
4. Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371 (2006). (Pubitemid 44924494)
5. Dandekar, S. Pathogenesis of HIV in the gastrointestinal tract. Curr. HIV/AIDS Rep. 4, 10-15 (2007). (Pubitemid 46555246)
6. Anthony, K. B. et al. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. J. Acquir. Immune Defic. Syndr. 33, 125-133 (2003). (Pubitemid 36793144)
7. Veazey, R. S. & Lackner, A. A. Getting to the guts of HIV pathogenesis. J. Exp. Med. 200, 697-700 (2004). (Pubitemid 39299456)
8. Tenorio, A. R. et al. The effect of aging on T-regulatory cell frequency in HIV infection. Clin. Immunol. 130, 298-303 (2009).
9. Gori, A. et al. Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J. Clin. Microbiol. 46, 757-758 (2008). (Pubitemid 351231331)
10. Saavedra, J. M., Bauman, N. A., Oung, I., Perman, J. A. & Yolken, R. H. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344, 1046-1049 (1994). (Pubitemid 24310035)
11. McKenna, P. et al. The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog. 4, e20 (2008).
12. Janoff, E. N. & Smith, P. D. Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management. Gastroenterol 120, 607-621 (2001). (Pubitemid 32171635)
13. Hummelen, R., Vo s, A. P., van't Land, B., van Norren, K. & Reid, G. Altered host-microbe interaction in HIV: a target for intervention with pro-and prebiotics. Int. Rev. Immunol. 29, 485-513 (2010).
14. Lievin-Le Moal, V. & Servin, A. L. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin. Microbiol. Rev. 19, 315-337 (2006).
15. Falk, P. G., Hooper, L. V., Midtvedt, T. & Gordon, J. I. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62, 1157-1170 (1998). (Pubitemid 28558295)
16. Kelly, D., Conway, S. & Aminov, R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol. 26, 326-333 (2005). (Pubitemid 40732666)
17. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. & Kasper, D. L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell Mol. Biol. 122, 107-118 (2005). (Pubitemid 40977944)
18. Gibson, G. R. & Roberfroid, M. B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125, 1401-1412 (1995).
19. Vos, A. P. et al. Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice. Pediatr. Allergy Immunol. 18, 304-312 (2007). (Pubitemid 46961749)
20. Moro, G. et al. Dosage-related bifidogenic effects of galacto-and fructooligosaccharides in formula-fed term infants. J. Pediatr. Gastroenterol. Nutr. 34, 291-295 (2002). (Pubitemid 34437523)
21. Arslanoglu, S. et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J. Nutr. 138, 1091-1095 (2008). (Pubitemid 351769134)
22. Griffiths, E. A. et al. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig. Dis. Sci. 49, 579-589 (2004). (Pubitemid 38992545)
23. Spindler-Vesel, A., Bengmark, S., Vovk, I., Cerovic, O. & Kompan, L. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J. Parenter. Enteral. Nutr. 31, 119-126 (2007).
24. Commane, D. M. et al. Effects of fermentation products of pro-and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr. Cancer 51, 102-109 (2005). (Pubitemid 40365988)
25. Wang, Z. et al. The role of bifidobacteria in gut barrier function after thermal injury in rats. J. Trauma. 61, 650-657 (2006). (Pubitemid 44400949)
26. Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481 (2008).
27. Hunt, P. W. et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197, 126-133 (2008). (Pubitemid 351263476)
28. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031 (2006). (Pubitemid 46018515)
29. Irvine, S. L. et al. Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J. Clin. Gastroenterol. 44, e201-e205 (2010).
30. Nazli, A. et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 8, e1000852 (2010).
31. Cao, W., Jamieson, B. D., Hultin, L. E., Hultin, P. M. & Detels, R. Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression. AIDS Res. Hum. Retroviruses 25, 183-191 (2009).
32. Azzoni, L. et al. Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity. J. Immunol. 168, 5764-5770 (2002). (Pubitemid 34556161)
33. Alter, G. et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106, 3366-3369 (2005). (Pubitemid 41609166)
34. Eger, K. A. & Unutmaz, D. Perturbation of natural killer cell function and receptors during HIV infection. Trends Microbiol. 12, 301-303 (2004). (Pubitemid 38829648)
35. Brunetta, E. et al. The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. Blood 114, 3822-3830 (2009).
36. Vaknin, I. et al. A common pathway mediated through Toll-like receptors leads to T-and natural killer-cell immunosuppression. Blood 111, 1437-1447 (2008). (Pubitemid 351213431)
37. D'Souza, M. et al. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction. J. Immunol. 179, 1979-1987 (2007).
38. Van Aerde, J., Alarcon, P. & Lam, W. Tolerance and safety of energy-dense enteral formulae for young children. Int. Pediatr. 18, 95-99 (2003). (Pubitemid 38111740)
39. Haarman, M. & Knol, J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 71, 2318-2324 (2005). (Pubitemid 40646972)
40. Haarman, M. & Knol, J. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 72, 2359-2365 (2006).
41. Pirnay, J. P. et al. Quantitation of Pseudomonas aeruginosa in wound biopsy samples: from bacterial culture to rapid'real-time'polymerase chain reaction. Crit. Care 4, 255-261 (2004).
42. Nadkarni, M. A., Martin, F. E., Jacques, N. A. & Hunter, N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148, 257-266 (2002). (Pubitemid 34083204)
43. Liu, A., Schisterman, E. F., Mazumdar, M. & Hu, J. Power and sample size calculation of comparative diagnostic accuracy studies with multiple correlated test results. Biom. J. 47, 140-150 (2005). (Pubitemid 40588600)
44. Franks, A. H. et al. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl. Environ. Microbiol. 64, 3336-3345 (1998). (Pubitemid 28411456)
45. Manz, W., Amann, R., Ludwig, W., Manz, W., Amann, R. & Ludwig, W. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 142, 1097-1106 (1996). (Pubitemid 26154919)
46. Poulsen, L. K., Licht, T. R., Rang, C., Krogfelt, K. A. & Molin, S. Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice. J. Bacteriol. 177, 5840-5845 (2005).
47. Hogardt, M. et al. Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J. Clin. Microbiol. 38, 818-825 (2000). (Pubitemid 30082687)
48. Harmsen, H. J. et al. Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria. FEMS Microbiol. Lett. 183, 125-129 (2000). (Pubitemid 30067735)
49. Zoetendal, E. G. et al. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl. Environ. Microbiol. 68, 3401-3407 (2002). (Pubitemid 34734038)
50. Jansen, G. J., Wildeboer-Veloo, A. C., Tonk, R. H., Franks, A. H. & Welling, G. W. Development and validation of an automated, microscopy-based method for enumeration of groups of intestinal bacteria. J. Microbiol. Methods 37, 215-221 (1999). (Pubitemid 29342289)
51. Zoetendal, E. G., Ben-Amor, K., Akkermans, A. D., Abee, T. & de Vos, W. M. DNA isolation protocols affect the detection limit of PCR approaches of bacteria in samples from the human gastrointestinal tract. Syst. Appl. Microbiol. 24, 405-410 (2001). (Pubitemid 34051764)